What are safe eye drop options for a pregnant woman with bacterial conjunctivitis who does not use contact lenses?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safe Eye Drop Options for Bacterial Conjunctivitis in Pregnancy (Non-Contact Lens User)

Erythromycin ophthalmic ointment and polymyxin B-containing combinations are the safest topical antibiotics for treating bacterial conjunctivitis during pregnancy, as they have established safety profiles in pregnant women. 1

First-Line Treatment Recommendation

Use erythromycin ophthalmic ointment or polymyxin B-trimethoprim ophthalmic solution as your primary treatment options. 1

  • Erythromycin is considered safe for topical ophthalmic use in pregnant women and nursing mothers, with no documented teratogenic effects. 1
  • Polymyxin B is also considered safe for topical application during pregnancy and lactation, as it has minimal systemic absorption due to its inability to penetrate the cornea. 1

Specific Dosing Regimens

Polymyxin B-Trimethoprim (Polytrim)

  • Instill one drop in the affected eye(s) every 3 hours (maximum 6 doses per day) for 7-10 days. 2, 3
  • This combination has proven efficacy against common bacterial conjunctivitis pathogens including Staphylococcus aureus, Haemophilus influenzae, and Streptococcus pneumoniae. 4, 5
  • Clinical trials demonstrate it is as effective as or superior to chloramphenicol for bacterial conjunctivitis. 5, 6

Important Pregnancy Considerations

Avoid trimethoprim if possible during first trimester, as it may interfere with folic acid metabolism. 3

  • Animal studies show trimethoprim is teratogenic in rats at 40 times the human dose, though human data from 186 pregnancies showed no increased congenital abnormalities (3.3% vs 4.5% placebo). 3
  • If trimethoprim-containing drops are used, the systemic absorption from topical ophthalmic use is minimal compared to oral administration, reducing theoretical risk. 3
  • The polymyxin B component has no known effects on fertility or fetal development, though formal animal reproduction studies have not been conducted. 3

Antibiotics to Avoid in Pregnancy

  • Fluoroquinolones (ciprofloxacin, norfloxacin, moxifloxacin): While effective for bacterial conjunctivitis 4, they are not first-line in pregnancy due to concerns about cartilage development in animal studies.
  • Chloramphenicol: Despite efficacy 5, 6, avoid due to rare but serious hematological toxicity concerns. 1
  • Aminoglycosides (gentamicin, tobramycin): Not preferred in pregnancy due to potential ototoxicity with systemic absorption, though topical risk is low. 1

Critical Safety Instructions for Patients

Instruct the patient on proper administration technique to minimize systemic absorption: 3

  • Avoid contaminating the applicator tip with material from the eye, fingers, or other sources to maintain sterility. 3
  • Apply gentle pressure to the lacrimal sac (nasolacrimal occlusion) for 1-2 minutes after instillation to reduce systemic absorption through nasal mucosa.
  • Discontinue use immediately and contact physician if redness, irritation, swelling, or pain persists or increases. 3

Expected Clinical Course

  • Most cases of bacterial conjunctivitis resolve within 7-10 days with appropriate antibiotic therapy. 2, 3
  • Clinical improvement should be evident within 2-3 days; if not, consider alternative diagnosis or resistant organisms. 7
  • The broad-spectrum activity of polymyxin B-trimethoprim covers the most common pathogens causing bacterial conjunctivitis. 5, 7

Common Pitfalls to Avoid

Do not prescribe prolonged courses of antibiotics, as this increases risk of selecting resistant organisms and fungal superinfection. 3

  • Limit treatment to 7-10 days maximum. 2, 3
  • If symptoms persist beyond this period, re-evaluate for viral etiology, allergic conjunctivitis, or resistant bacteria. 3
  • Pregnant patients should not wear contact lenses during treatment, though this patient is already a non-contact lens user. 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.